Teva Pharmaceutical Industries Ltd. Deal History & Licensing Activity
Teva Pharmaceutical Industries Ltd. is a life sciences. Over the past three years, Teva Pharmaceutical Industries Ltd. has been involved in 6 licensing and acquisition transactions, with a primary focus on Small Molecules (9 deals).
Deals (12mo)
4
Active Trials
0
Top Modality
Small Molecules
Focus Area
Mega Deals
Teva Pharmaceutical Industries Ltd. Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Teva Pharmaceutical Industries Ltd. in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| experimental Tourette drug | Teva Pharmaceutical | Small Molecules | Unknown | acquisition | Apr 2026 |
| Experimental Tourette drug | Teva Pharmaceutical | Small Molecules | Unknown | acquisition | Apr 2026 |
| Experimental Tourette drug | Teva | Small Molecules | Unknown | acquisition |
Teva Pharmaceutical Industries Ltd. Pipeline Focus
Therapeutic areas and modalities where Teva Pharmaceutical Industries Ltd. is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches Teva Pharmaceutical Industries Ltd.'s Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Mega Deals assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Gastroenterology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for gastroenterology
Infectious Disease Deal Benchmarks
Market sizing, deal terms, and competitive landscape for infectious disease
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Antibodies Benchmarks
Upfront, milestone, and royalty benchmarks for antibodies deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
About Teva Pharmaceutical Industries Ltd. Licensing & Deal Activity
Teva Pharmaceutical Industries Ltd. is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 6 deals over the past three years, Teva Pharmaceutical Industries Ltd. ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Teva Pharmaceutical Industries Ltd. include Mega Deals (8 deals and trials), Gastroenterology (2 deals and trials), and Infectious Disease (1 deal and trial). In terms of modality, Teva Pharmaceutical Industries Ltd. has shown particular interest in small molecules, antibodies.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Teva Pharmaceutical Industries Ltd. and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Teva Pharmaceutical Industries Ltd.'s historical deal terms, or explore all company profiles to find the best partner match for your pipeline.